rxstat › Shortages › Pramipexole Dihydrochloride

Pramipexole Dihydrochloride shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Pramipexole Dihydrochloride products are in shortage in Canada (4 of 40 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
Products affected
4 / 40
In shortage since
Feb 4, 2026
Est. full return
Sep 4, 2026
Reports on file
135
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-PRAMIPEXOLE
1.5MG · TABLET · APOTEX INC
DIN 02292408 · since Mar 3, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-PRAMIPEXOLE
0.25MG · TABLET · APOTEX INC
DIN 02292378 · since Jun 16, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-PRAMIPEXOLE
0.5MG · TABLET · APOTEX INC
DIN 02292386 · since Jun 2, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACT PRAMIPEXOLE
0.25MG · TABLET · TEVA CANADA LIMITED
DIN 02297302 · since Feb 4, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
MIRAPEX
0.25MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02237145 · ended May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRAPEX
0.125MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02297256 · ended May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
ACT PRAMIPEXOLE
1.5MG · TABLET · TEVA CANADA LIMITED
DIN 02297337 · ended Oct 1, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
0.5MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02309130 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
0.25MG · TABLET · SANIS HEALTH INC
DIN 02367602 · ended Apr 24, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
1.5MG · TABLET · PRO DOC LIMITEE
DIN 02325837 · ended Apr 16, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ PRAMIPEXOLE
1MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02315289 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ PRAMIPEXOLE
0.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02315270 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Pramipexole Dihydrochloride is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Pramipexole Dihydrochloride is classified under “DOPAMINERGIC AGENTS” (ATC N04BC).

Recent changes

Common questions

When will Pramipexole Dihydrochloride be back in stock in Canada?

The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Pramipexole Dihydrochloride in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (dopaminergic agents)

Widespread shortageRasagiline4 of 7 reported products affected · est. return Jul 31, 2026Partial shortageApomorphine1 of 6 reported products affectedPartial shortageCarbidopa Levodopa4 of 21 reported products affected · est. return Nov 30, 2026Partial shortageEntacapone1 of 4 reported products affected · est. return Jul 20, 2026Partial shortageRopinirole5 of 23 reported products affected · est. return Aug 10, 2026Partial shortageSelegiline1 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.